Latest Breaking News On - Kishan amarukishan - Page 1 : comparemela.com

/PRNewswire/ ViewRay, Inc. (NASDAQ: VRAY) today announced that interim data from the single center Phase III randomized MIRAGE trial, led by UCLA, comparing.

United statesSan franciscoKishan amarukishanAmar kishanPrnewswire viewray incAmerican society of clinical oncologyDepartment of defenseNational institutes of healthInternational prostate symptom scoreVarian medical systems incGenitourinary oncology serviceAmerican society for radiation oncologyViewray incJonsson comprehensive cancer foundationProstate cancer foundationClinical oncology